CHSC Mobile Screening Units bring comprehensive health checks directly to your workplace—at no additional charge—making preventive healthcare convenient, efficient, and accessible for your entire team.
CHSC Mobile Screening Units bring comprehensive health checks directly to your workplace—at no additional charge—making preventive healthcare convenient, efficient, and accessible for your entire team.
Over one million chest X-rays analyzed in one of the world’s largest real-world AI TB screening studies.
Capital Health Screening Centre in Abu Dhabi, part of the M42 group, is proud to announce groundbreaking results from one of the world’s largest population-based studies on AI-powered tuberculosis (TB) screening. These findings were recently published in the prestigious scientific journal npj Digital Medicine – Nature, read the article here: https://www.nature.com/articles/s41746-025-01832-7
This large-scale study represents one of the most significant real-world clinical validations of Artificial Intelligence in healthcare, with over one million chest X-rays (CXRs) analyzed to evaluate its effectiveness in detecting TB.
The research assessed Capital Health Screening Centre’s AI Radiology in Screening TB (AIRIS-TB) model, which empowers radiologists by enabling them to focus on more complex cases. The model achieved an outstanding Area Under the Receiver Operating Characteristic Curve (AUROC) of 98.5% and recorded a 0% false-negative rate across the dataset. These results demonstrate exceptional levels of accuracy, safety, and scalability.
The publication of these breakthrough findings in a leading international journal highlights Capital Health Screening Centre and M42’s global leadership in AI-driven healthcare solutions. It also represents a significant milestone in advancing the worldwide fight against tuberculosis and in transforming the way healthcare is delivered, diagnosed, and experienced.
